Skip to main content

Table 2 Clinical, anthropometric and laboratory characteristics of PCOS groups

From: Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome

Parameters PCO patients (n = 180)
NGT Group (mean ± SD)
(n = 75)
IGT Group (mean ± SD)
(n = 65)
T2DM Group (mean ± SD)
(n = 40)
Systolic blood pressure (mm Hg) 127.76 ± 7.21 134.49 ± 4.74a 139.67 ± 7.04b,c
Diastolic blood pressure (mm Hg) 83.8 ± 3.86 87.85 ± 6.33a 90.98 ± 5.80b,c
Hirsutism score 13.78 ± 2.594 13.42 ± 2.9 13.29 ± 1.42
Body mass index (kg/m2) 32.96 ± 14.25 30.11 ± 4.41 32.65 ± 5.73
Waist/hip ratio 0.96 ± 0.212 1.34 ± 0.27a 1.17 ± 0.27b,c
Ovarian volume 9.88 ± 0.491 10.75 ± 1.21a 11.89 ± 1.4b,c
AFC 11.38 ± 0.491 12.25 ± 1.17a 13.39 ± 1.6b,c
FMI (kg/m2) 6.20 ± 0.68 8.7 ± 0.63a 9.49 ± 0.63b,c
FFMI (kg/m2) 17.65 ± 1.96 25.02 ± 1.82a 27.17 ± 1.06b,c
Total cholesterol (mg/dL) 191.21 ± 54.43 201.5 ± 54.43 209.02 ± 43.32
Triglycerides (mg/dL) 174.02 ± 55.3 184.2 ± 57.19 216.04 ± 73.1b,c
LDL cholesterol (mg/dL) 168.15 ± 61.11 163.17 ± 57.96 166.46 ± 63.11
HDL cholesterol (mg/dL) 41.46 ± 11.78 36.21 ± 13.85a 39.8 ± 15.8
FPG (mg/dL) 91.1 ± 6.84 108.16 ± 12.50a 140.5 ± 12.7b,c
2-h blood glucose (mg/dL) 130.28 ± 23.2 171.94 ± 28.68a 212.8 ± 30.1b,c
FSI (lU/mL) 13.5 ± 3.289 26.96 ± 5.51a 21.1 ± 3.34b,c
HOMA-IR 2.85 ± .855 6.25 ± 1.44a 5.34 ± 0.647b,c
HOMA-β 139.23 ± 54.11 124.4 ± 35.3a 108.6 ± 41.55b,c
HbA1c (%) 5.66 ± 0.35 6.37 ± 0.615a 7.62 ± 0.983b,c
Total testosterone (ng/mL) 0.9 ± 0.231 0.99 ± 0.304a 1.07 ± 0.155b,c
Free androgen index 1.813 ± 0.98 2.88 ± 0.81a 3.4 ± 0.69b,c
FSH (mIU/mL) 6.02 ± 1.314 7.107 ± 1.06a 7.05 ± 0.985b
LH (mIU/mL) 9.45 ± 0.491 10.44 ± 1.15a 11.98 ± 0.201b,c
LH/FSH 1.63 ± 0.341 1.48 ± 0.144a 1.73 ± 0.241c
SHBG (nmol/L) 33.54 ± 3.108 26.23 ± 2.011a 24.197 ± 0.96b,c
DHEA-S (mg/mL) 2.17 ± 0.245 2.43 ± 0.241a 2.66 ± 0.286b,c
Androstenedione (ng/mL) 1.23 ± 0.371 1.91 ± 0.539a 1.88 ± 0.43
hs-CRP (μg/ml) 4.92 ± 0.761 5.79 ± 0.760a 6.37 ± 0.91b,c
WBC count (cell×103/μl) 4.79 ± 0.713 8.45 ± 2.27a 8.58 ± 1.281b,c
CIMT (mm) 0.96 ± 0.263 1.09 ± 0.36a 1.74 ± 0.467b,c
Serum ICAM-1 (ng/ml) 281.3 ± 95.29 509.4 ± 82.16a 594.6 ± 156.12b,c
Relative ICAM expression levels 2.68 ± 0.85 5.7 ± 1.52a 6.05 ± 2.119b,c
  1. NGT Normal glucose tolerance, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitus, FSI fasting serum insulin, FPG fasting plasma glucose, AFC antral follicle cells, FMI fat mass index, FFMI fat free mass index, HOMA-IR homeostasis model assessments of insulin resistance, DHEA dehydroepiandrosterone
  2. a significant difference between IGT vs NGT
  3. b significant difference between T2DM vs NGT.,c significant difference between T2DM vs IGT,